LDR | |
01185nam a22002891a 4500 |
001 |
|
002165929 |
003 |
|
MiAaHDL |
005 |
|
20210817000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
900814s1990 nyu b 10100 eng |
010 |
⊔ |
⊔ |
‡a89021545
|
020 |
⊔ |
⊔ |
‡a0471567728
|
035 |
⊔ |
⊔ |
‡a(MiU)990021659290106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990021659290106381
|
035 |
⊔ |
⊔ |
‡a(OCoLC)20933400
|
035 |
⊔ |
⊔ |
‡a(RLIN)MIUG90-B42885
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph002165929
|
040 |
⊔ |
⊔ |
‡aDLC
‡cDLC
‡dNhD
‡dCSt
‡dMiU
|
050 |
0 |
0 |
‡aRB155.5
‡b.B56 1990
|
245 |
0 |
0 |
‡aBiotechnology and human genetic predisposition to disease :
‡bproceedings of a UCLA symposium held at Steamboat Springs, Colorado, March 27-April 3, 1989 /
‡ceditors, Charles R. Cantor ... [et al.].
|
260 |
⊔ |
⊔ |
‡aNew York, N.Y. :
‡bWiley-Liss,
‡c1990.
|
300 |
⊔ |
⊔ |
‡axviii, 241 p. :
‡bill. ;
‡c24 cm.
|
490 |
0 |
⊔ |
‡aUCLA symposia on molecular and cellular biology ;
‡v126
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aGene mapping
‡xCongresses.
|
650 |
⊔ |
0 |
‡aGene therapy
‡vCongresses.
|
650 |
⊔ |
0 |
‡aHuman chromosomes
‡xAnalysis
‡xCongresses.
|
650 |
⊔ |
0 |
‡aGenetic disorders
‡xSusceptibility
‡xCongresses.
|
700 |
1 |
⊔ |
‡aCantor, Charles R.,
‡d1942-
|
CID |
⊔ |
⊔ |
‡a002165929
|
DAT |
0 |
⊔ |
‡a19920428000000.0
‡b20210817000000.0
|
DAT |
1 |
⊔ |
‡a20210918060716.0
‡b2023-10-12T17:49:49Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990021659290106381
‡aMiU
‡bSDR
‡cMIU
‡pmdp.39015018501463
‡sMIU
‡1990021659290106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20231012
‡sgoogle
‡umdp.39015018501463
‡y1990
‡ric
‡qbib
‡tUS bib date1 >= 1930
|